TITLE

Cost-effective cervical cancer prevention possible in Brazil

PUB. DATE
September 2007
SOURCE
PharmacoEconomics & Outcomes News;9/8/2007, Issue 536, p4
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article discusses research being done on the development of a cost effective strategy for cervical cancer prevention in Brazil. It references a study by S. J. Goldie et al. published in the August 2007 issue of the "Vaccine." The researchers concluded that a human papillomavirus (HPV) vaccination program would be a cost effective strategy for preventing cervical cancer in Brazil. The researchers utilized an empirically calibrated simulation model of cervical carcinogenesis to evaluate HPV 16 and 18 vaccination of adolescent females.
ACCESSION #
26902737

 

Related Articles

  • Monitoring the control of human papillomavirus (HPV) infection and related diseases in Australia: towards a national HPV surveillance strategy. Brotherton, Julia M. L.; Kaldor, John M.; Garland, Suzanne M. // Sexual Health (14485028);Sep2010, Vol. 7 Issue 3, p310 

    The article provides information on a study which proposed a possible multifaceted strategy to human papillomavirus (HPV) related surveillance in Australia following the adoption of a national HPV vaccination program. Main components discussed in detail are monitoring of vaccine coverage,...

  • Vaccine proven to prevent cervical cancer.  // GP: General Practitioner;5/11/2007, p2 

    The article offers information regarding a study on the HPV vaccine Gardasil undertaken by the researchers of the U.S. The results of the study of Gardasil have revealed that it is nearly 100 per cent effective against the two types of HPV responsible for most cases of cervical cancer. The study...

  • Epidemiology of cervical cancer in Latin America. Capote Negrin, Luis G. // Ecancermedicalscience;2015, Vol. 9 Issue 577-607, p1 

    The basic aspects of the descriptive epidemiology of cervical cancer in Latin America are presented. A decrease in the incidence and mortality rates has been observed in the period from 2000 to 2012 in all countries across the region, this has not occurred at the same proportions, and in many...

  • Formative research to shape HPV vaccine introduction strategies in Peru. Bartolini, Rosario M.; Drake, Jennifer Kidwell; Creed-Kanashiro, Hilary M.; Díaz-Otoya, Margarita M.; Mosqueira-Lovón, Nelly Rocío; Penny, Mary E.; Winkler, Jennifer L.; LaMontagne, Scott; Bingham, Allison // Salud Pública de México;may2010, Vol. 52 Issue 3, p226 

    Objetivo. Comprender el contexto sociocultural, las capacidades del sistema de salud y las condiciones políticas vinculadas al cáncer cervical y a la vacuna contra el VPH para diseñar una estrategia apropiada de introducción de la vacuna contra el VPH. Material y métodos....

  • Aspects of Prophylactic Vaccination against Cervical Cancer and Other Human Papillomavirus-Related Cancers in Developing Countries. Natunen, Kari; Lehtinen, Johannes; Namujju, Proscovia; Sellors, John; Lehtinen, Matti // Infectious Diseases in Obstetrics & Gynecology;2011, Vol. 2011, Special section p1 

    Cervical cancer and other human papillomavirus- (HPV-) related cancers are preventable, but preventive measures implemented in developing countries and especially in low-income rural regions have not been effective. Cervical cancer burden derived from sexually transmitted HPV infections is the...

  • Identification of human papillomaviruses from formalin-fixed, paraffin-embedded pre-cancer and invasive cervical cancer specimens in Zambia: a cross-sectional study. Bateman, Allen C.; Katundu, Katundu; Polepole, Pascal; Shibemba, Aaron; Mwanahamuntu, Mulindi; Dittmer, Dirk P.; Parham, Groesbeck P.; Chibwesha, Carla J. // Virology Journal;2015, Vol. 12 Issue 1, p81 

    Background The most common human papillomavirus (HPV) genotypes isolated from cervical cancer in select African countries are HPV-16, HPV-18, HPV-35, and HPV-45, but the most common genotypes in Zambia are unknown. The overall objective of this study was to assess the potential impact of current...

  • Genetic Variability in L1 and L2 Genes of HPV-16 and HPV-58 in Southwest China. Yaofei Yue; Hongying Yang; Kun Wu; Lijuan Yang; Junying Chen; Xinwei Huang; Yue Pan; Youqing Ruan; Yujiao Zhao; Xinan Shi; Qiangming Sun; Qihan Li // PLoS ONE;Jan2013, Vol. 8 Issue 1, Special section p1 

    HPV account for most of the incidence of cervical cancer. Approximately 90% of anal cancers and a smaller subset (<50%) of other cancers (oropharyngeal, penile, vaginal, vulvar) are also attributed to HPV. The L1 protein comprising HPV vaccine formulations elicits high-titre neutralizing...

  • Addressing Health Inequalities in the Delivery of the Human Papillomavirus Vaccination Programme: Examining the Role of the School Nurse. Boyce, Tammy; Holmes, Alison; Fielding, Richard // PLoS ONE;Sep2012, Vol. 7 Issue 9, Special section p1 

    Background: HPV immunisation of adolescent girls is expected to have a significant impact in the reduction of cervical cancer. UK The HPV immunisation programme is primarily delivered by school nurses. We examine the role of school nurses in delivering the HPV immunisation programme and their...

  • Knowledge of Health Care Providers on HPV Related Issues in Cervical Cancer. HUSSAIN, F.; FLORA, M. S.; NAHAR, K.; KHAN, M. // Journal of Bangladesh College of Physicians & Surgeons;Oct2011, Vol. 29 Issue 4, p213 

    Background: The field of cervical cancer prevention is rapidly evolving because of identification of Human Papilloma Virus (HPV) as the necessary cause of disease. HPV vaccines are now in the market.For successful triggering of cervical cancer prevention program, HPV informations should be...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics